Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Galliford Try wins places on £9.5bn CPC construction framework

(Sharecast News) - Construction group Galliford Try said on Tuesday that it has been appointed to the new £9.5bn Crescent Purchasing Consortium Construction and Capital Works framework, securing places on all five regional lots covering England, Wales and Scotland. Galliford Try said the framework, which runs for up to eight years, supports construction and refurbishment projects across education and the wider public sector.

The FTSE 250-listed firm will work across a broad mix of schemes, from schools, colleges and universities to healthcare facilities and civic infrastructure.

Chief executive Bill Hocking said: "We are pleased with our appointment to this new education-related framework, reflecting our position as one of the leading contractors for the sector. We look forward to working with CPC and its clients as we continue to develop high-quality educational facilities and wider public sector projects for communities across the country."

As of 1000 BST, Galliford Try shares were up 1.45% at 596.55p.

Reporting by Iain Gilbert at Sharecast.com

See latest RNS at Investegate

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.